Rinvoq ER 15 MG tablet UU 30S
Ended Awarded Last action
- Contract number
- SPE2DR26F4C9E
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $24,566
Award facts
- Contract value 100% obligated
- $24,566.46 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $24,566.46 to AmerisourceBergen Drug Corp for RINVOQ ER 15 mg tablets (30-count unit of use packaging). This competitively awarded, firm fixed-price delivery order was executed on December 4, 2025, with an ultimate completion date of December 5, 2025. The award represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, a $999.999 billion vehicle designated SPE2DX that runs through December 2026. This IDC serves as a comprehensive global pharmaceutical support vehicle enabling AmerisourceBergen to supply a wide range of medications and medical supplies to support military healthcare programs worldwide.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as a critical vendor for federal medical procurement needs supporting military and veteran healthcare systems. The company's federal contract portfolio demonstrates extensive experience delivering brand-name and generic medications, vaccines, medical devices, and specialized healthcare commodities across multiple therapeutic domains. Performance will occur at AmerisourceBergen's Conshohocken facility, and no set-aside designation was applied to this award, indicating it was procured through open competition on the DLA's existing pharmaceutical prime vendor contract vehicle.
Quick answers
Who was awarded contract SPE2DR26F4C9E?
SPE2DR26F4C9E was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 4, 2025.
How much is contract SPE2DR26F4C9E worth?
The government has obligated $24,566 on SPE2DR26F4C9E.
Is contract SPE2DR26F4C9E an order under another contract?
Yes. SPE2DR26F4C9E is a delivery order under SPE2DR25D3012, an indefinite delivery contract.
Was contract SPE2DR26F4C9E competed?
The extent of competition for SPE2DR26F4C9E was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award